Dual therapy based on raltegravir and boosted protease inhibitors – the experience of Polish centers

INTRODUCTION: The aim of the study was to present the experience of Polish centers regarding dual therapy based on the integrase inhibitor raltegravir (RAL) and ritonavir-boosted protease inhibitors (PI/r) for treating treatment-naïve and -experienced HIV-infected patients. MATERIAL AND METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabłonowska, Elżbieta, Pulik, Piotr, Kalinowska, Anna, Gąsiorowski, Jacek, Parczewski, Miłosz, Bociąga-Jasik, Monika, Mularska, Elżbieta, Pulik, Łukasz, Siwak, Ewa, Wójcik, Kamila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040130/
https://www.ncbi.nlm.nih.gov/pubmed/30002705
http://dx.doi.org/10.5114/aoms.2016.62445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040130/
https://www.ncbi.nlm.nih.gov/pubmed/30002705
http://dx.doi.org/10.5114/aoms.2016.62445

Ejemplares similares